Abstract
Even before the discovery of radioactivity, uranium (pitchblende) was known to be toxic. Nineteenth century reports describe the use of uranium as a nephrotoxic agent in the study of kidney function. In the early days of the Manhattan Project, studies into both the chemotoxic and radiotoxic effects of uranium were undertaken. The original protection guides for uranium grew out of these studies. This chapter is limited to the problems of environmental and personnel protection. Of equal importance are those problems of criticality control which must be considered in the processing of uranium materials enriched in 235U (American National Standards Institute Committee N16, 1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American National Standards Institute: Nuclear criticality safety in operations with fissionable materials outside reactors. N16. 1-1969, American Nuclear Society, Hinsdale, Illinois, 1970.
American Standards Association: American standard safety code for head, eye, and respiratory protection. Z2. 1-1959, American Standards Association, Inc., New York, New York, 1960.
Atomic Industrial Forum, Inc.: American national standard guide to sampling airborne radioactive materials in nuclear facilities. ANSI N13. 1-1969, American National Standards Institute, Inc., New York, New York, 1969.
Boni, A.: Urinalysis method for enriched uranium. Hlth Phys. 2, 3, 288–290 (1960).
Brunskill, R. T., Hermiston, S. T.: The detection and measurement of airborne contamination in major plutonium facilities. Proceedings of the First International Congress of Radiation Protection, part 2, p. 961–973. London, United Kingdom: Pergamon Press 1968.
Caldwell, R., Schnell, E., Potter, T.: Bioassay correlation with breathing-zone sampling. UCRL-18140, University of California, Berkeley, California, 1968.
Code of Federal Regulations: Atomic Energy Title 10, part 20. U.S.A. Office of the Federal Register, 1963.
Cofield, R. E.: In vivo gamma counting as a measurement of uranium in the human lung. Hlth Phys. 2, 269–287 (1960).
Fischoff, L .: Correlation between two-stage air sampling data on the excretion of uranium in urine. NLCO-869, National Lead Company, Cincinnati, Ohio, April 1963.
Ford, M. R.: Comments on intake guides for various isotopes and isotopic mixtures of uranium. ORNL-3697, Union Carbide Corporation, Oak Ridge, Tennessee, October 1964.
Fraser, D. C.: Health physics problems associated with the production of experimental reactor fuels containing PuO2. Hlth Phys. 13, 10, 1133–1143 (1967).
Harley, J. H.: Manual of standard procedures. NYO-4700, 3rd Ed., United States Atomic Energy Commission, New York, New York, Sept. 1970.
Harrington, C. D., Ruehle, A. E.: Uranium production technology. Princeton, New Jersey: D. van Nostrand Company, Inc. 1959.
Harris, W. B., Kingsley, I.: The industrial hygiene of uranium fabrication. Arch, industr. Hlth 19, 540–565 (1959).
Heatherton, R. C., Huesing, J. A.: A uranium refinery and metal plant urine program and data. Symposium on Occupational Health Experience and Practices in the Uranium Industry, HASL-58, United States Atomic Energy Commission, New York, New York, 1959.
Helgeson, G. R.: Personal communication. Helgeson Nuclear Services, Inc., Pleasanton, California, 1971.
Hursh, J .: Bioassay procedures for uranium. Chemical Methods for Routine Bioassay, AECU-4024, University of Rochester, Rochester, New York, Nov. 1958.
Hyatt, E. C., Moss, W. D., Schulte, H. F.: Particle size studies on uranium aerosols from machining and metallurgy operations. Amer. industr. Hyg. Ass. J. 20, 99–107 (1959).
International Commission on Radiological Protection: Report of committee II on permissible dose for internal radiation. London, United Kingdom: Pergamon Press 1959.
International Commission on Radiological Protection: Publication 6. London, United Kingdom: Pergamon Press 1962.
Jackson, S.: Estimation of uranium from urine analysis. Assessment of radioactivity in man, vol. II, p. 549–561. Vienna: International Atomic Energy Agency 1964.
Kramer, H. H., Malinski, V. J., Ness, H. W.: Urinalysis for uranium-235 and uranium-238 by neutron activation analysis. Hlth Phys. 13, 1, 27–30 (1967).
Laurer, G. R., Eisenbud, M.: In vivo measurement of nuclides emitting soft penetrating radiations. Diagnosis and treatment of deposited radionuclides, p. 189–207. Amsterdam, The Netherlands: Excerpta Medica Foundation 1968.
Lippman, M .: Correlation of urine data and medical findings with environmental exposure to uranium compounds. Symposium on Occupational Health Experience and Practices in the Uranium Industry, HASL-58, United States Atomic Energy Commission, New York, New York, 1959.
Lockhart, L. B., Patterson, R. J., Jr., Anderson, W. L.: Characteristics of air filter media used for monitoring airborne radioactivity. NRL-6054, U.S. Naval Research Laboratory, Washington, D.C., March 1964.
National Bureau of Standards: Maximum permissible body burdens and maximum permissible concentrations of radionuclides in air and in water for occupational exposure. Handbook 69, U.S. Department of Commerce, Washington, D.C., June 1959.
Owen, F. E.: Beta-gamma dose rates from 232U and 233U, HW-81964. General Electric Company, Richland, Washington, April 1964.
Patterson, G. R .: Evaluation and control of internal exposure from enriched uranium at Y-12. Symposium on Occupational Health Experience and Practices in the Uranium Industry, HASL-58, United States Atomic Energy Commission, New York, New York, 1959.
Patton, F. S., Googin, J. M., Griffith, W. L.: Enriched uranium processing, international series of monographs on nuclear energy. Division IX. Chemical engineering, vol. 2. New York, N.Y.: The Macmillian Company 1963.
Price, G. R., Ferretti, R. J., Schwartz, S.: Fluorophotometric determination of uranium. Analyt. Chem. 25, 322–331 (1953).
Quastel, M. R., Taniguchi, H., Overton, T. R., Abbott, J. D.: Excretion and retention by humans of chronically inhaled uranium dioxide. Hlth Phys. 18, 3, 233–244 (1970).
Ross, J. E.: Correlation of urine data with environmental exposure to uranium. Symposium on Occupational Health Experience and Practices in the Uranium Industry, HASL-58, United States Atomic Energy Commission, New York, N.Y., 1959.
Sanders, M.: Automated smears program for radioactive material. Hlth Phys. 10, 5, 341–344 (1964).
Sanders, M.: Innovations in air-monitoring techniques for large-scale programs. Assessment of airborne radioactivity. Vienna: International Atomic Energy Agency 1967.
Saxby, W. N., Taylor, N. A., Garland, J., Rundo, J., Newton, D.: A case of inhalation of enriched uranium dust. Assessment of radioactivity in man, vol. II, p. 535–547. Vienna: International Atomic Energy Agency 1964.
Schultz, N. B .: Inhalation cases of enriched insoluble uranium oxides. Proceedings of the first International Congress of Radiation Protection, part 2, p. 1205–1217. London, United Kingdom: Pergamon Press 1968.
Schultz, N. B., Becher, A. F.: Correlation of uranium alpha surface contamination, airborne concentrations, and urinary excretion rates. Hlth Phys. 9, 901–909 (1963).
Scott, L. M., West, C. M.: Detection and evaluation of uranium exposures. Assessment of radioactivity in man, vol. II, p. 523–533. Vienna: International Atomic Energy Agency 1964.
Scott, L. M., West, C. M.: Health physics application of in vivo gamma spectrometry in a uranium processing plant. Diagnosis and treatment of deposited radionuclides, p. 543–552. Amsterdam, The Netherlands: Excerpta Medica Foundation 1968.
Scott, L. M., West, C. M., Abele, H. M., Bryant, E. H., Cromwell, H. H.: Design and development of a mobile in vivo radiation monitoring laboratory. Amer. ind. Hyg. Ass. J. 30, 165–169 (1969).
Sill, C. M.: Separation and radiochemical determination of uranium and the transuranium elements using barium sulfate. Hlth Phys. 17, 1, 89–107 (1969).
Sill, C. M., Williams, R. L.: Radiochemical determination of uranium and the transuranium elements in process solutions and environmental samples. Analyt. Chem. 41, 1624–1632 (1969).
Steckel, L. M., West, C. M.: Characterization of Y-12 uranium process materials correlated with in vivo experience. Y-1544-A, Union Carbide Corporation, Oak Ridge, Tennessee, July 1966.
Task Group on Lung Dynamics: Deposition and retention models for internal dosimetry of the human respiratory tract. Hlth Phys. 12, 2, 173–207 (1966).
Trojanowski, M. M., Bouton, R. Z.: A method of determining enriched uranium in urine. KAPL-667 General Electric Company, Schenectady, New York, 1951.
West, C. M., Reavis, J. P.: Use of statistics in an applied health physics program. Hlth Phys. 10, 5, 345–351 (1964).
West, C. M., Scott, L. M.: A comparison of uranium cases showing long chest burden retentions. Hlth Phys. 12, 1545–1555 (1966).
West, C. M., Scott, L. M.: Uranium cases showing long chest burden retention — an update. Hlth Phys. 17, 781–791 (1969).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Springer-Verlag/Berlin Heidelberg
About this chapter
Cite this chapter
Scott, L.M. (1973). Environmental Monitoring and Personnel Protection in Uranium Processing. In: Hodge, H.C., Hursh, J.B., Stannard, J.N. (eds) Uranium · Plutonium Transplutonic Elements. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65551-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-65551-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65553-1
Online ISBN: 978-3-642-65551-7
eBook Packages: Springer Book Archive